Barclays Downgrades Edwards Lifesciences (EW) to Equalweight
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $89.79 -0.04%
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Barclays downgraded Edwards Lifesciences (NYSE: EW) from Overweight to Equalweight, price target lowered from $95 to $85.
For more ratings news on Edwards Lifesciences click here and for the rating history of Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $74.67 yesterday.
For more ratings news on Edwards Lifesciences click here and for the rating history of Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $74.67 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Downgrades Renault SA (RNO:FP) (RNSDF) to Equalweight
- JPMorgan Downgrades Kuaishou Technology (1024:HK) to Neutral
- Deutsche Bank Downgrades Straumann Holding AG (STMN:SW) (SAUHF) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
